SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosure of Voting results of Court Convened Meeting (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of Court Convened Meeting, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Voting Results Of National Company Law Tribunal ("NCLT") Convened Meeting Of The Equity Shareholders Of The Company Held On June 04, 2019.
Ref: Clause 44(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we enclose herewith the details of the result of remote e-voting and electronic voting conducted at the NCLT convened meeting of equity shareholders of Sun Pharmaceutical Industries Limited held on June 04, 2019 at 10:15 a.m. 1ST at Prof. Chandravadan C. Mehta Auditorium - General Education Centre, Maharaja Sayajirao University of Baroda, Near D. N. Hall, Pratap Gunj, Vadodara-390 002, Gujarat, India for approval of the Composite Scheme of Arrangement among Sun Pharmaceutical Industries Limited and Sun Pharma (Netherlands) B.V., and Sun Pharmaceutical Holdings USA Inc., and their respective members and creditors ("Composite Scheme of Arrangement") along with the Scrutinizer''s Report. The said Composite Scheme of Arrangement was approved by the requisite majority of equity shareholders through remote e-voting and electronic voting conducted at the Meeting. We request you to kindly take note of the same. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Submission Of Advertisement Published In Newspapers Regarding Notice For Transfer Of Equity Shares And Unclaimed Dividend To The Investor Education And Protection Fund (IEPF) Account
Submission of Advertisement published in newspapers regarding Notice for transfer of equity shares and unclaimed dividend to the Investor Education and Protection Fund (IEPF) Account. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the advertisement published in the following newspapers: 1. Financial Express dated June 05, 2019- Mumbai Edition 2. Financial Express dated June 05, 2019- Ahmedabad Edition 3. Financial Express dated June 05, 2019- Ahmedabad Edition (Gujarati Language) This is for your information and records. Sun Pharmaceutical Industries Ltd - 524715 - Sub: Proceedings Of National Company Law Tribunal ("NCLT") Convened Separate Meetings Of The Equity Shareholders And Unsecured Creditors Of Sun Pharmaceutical Industries Limited ("The Company") Held Today, June 04, 2019
Proceedings of National Company Law Tribunal ("NCLT") convened separate meetings of the equity shareholders and unsecured creditors of Sun Pharmaceutical Industries Limited ("the Company") held today, June 04, 2019 Sun Pharma hovers above a key support
A break above 500 is needed to alter the downtrend and take the stock up to 600 Sudhir Valia steps down from role of Sun Pharma's whole-time director
Shares of Sun Pharmaceutical Industries closed at Rs 422.85 apiece on the BSE, up 2.41 per cent Sun Pharmaceutical Industries Ltd - 524715 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report24/05/2019 3 Name of the Certifying Firm KJB & CO LLP 4 Name of the Certifying Individual Alpeshkumar Panchal 5Membership TypeACS 6 Membership Number 49008 7 CP No. 20120 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Designation of Mr. Sudhir V. Valia : Please note that Mr. Sudhir Valia stepped down from the position of Whole-time Director of the Company to Non-Executive Director of the Company, with effect from 29th May, 2019, therefore he shall continue as a Non-Executive and Non-Independent Director of the Company. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to fourth quarter FY19 financials, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you, SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Board recommends Dividend
Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended payment of dividend of Rs. 2.75/- (Rupees Two and parse seventy five Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2019, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or about last week of August, 2019 or first week of September, 2019.